Key facts
- SubQ Bionics’s last known valuation is $6.5M (Mar 2026).
- It has raised $1.5M; the latest was Seed Round ($3.0M) in Jul 2026.
- Notable investors include Innovation Authority, Mayo Clinic Ventures, Various Angels, YEDA Technology Transfer.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for SubQ Bionics
- ·The full record, as it builds
Funding rounds
No funding rounds for SubQ Bionics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About SubQ Bionics
Operator of a medical technology intended to alleviate the chronic pain and debilitating symptoms of lymphedema for oncology patients. The company offers a revolutionary subcutaneous ceramic implant and AI-enabled pump system that mechanically restores lymphatic circulation to provide a discreet, life-changing alternative to lifelong compression therapy by reducing swelling, fatigue, and physical discomfort, enabling customers to reclaim control over their bodies and improve their overall quality of life while moving beyond the limitations of traditional, non-surgical management.
- Sector
- Healthcare
- HQ
- Stillwater, MN, United States
- Founded
- 2025
- Employees
- 3
- Website
- subqbionics.com/
- Ownership
- Privately Held (backing)
SubQ Bionics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in SubQ Bionics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on SubQ Bionics in its N-PORT filings yet. We sweep new filings monthly.